US pre-open: Stocks mixed following Dow's strong start to the month

Wall Street futures were mixed ahead of the bell on Tuesday after the Dow Jones and S&P 500 saw out the previous session in the green.

As of 1235 BST, Dow Jones futures were up 0.06%, while S&P 500 and Nasdaq-100 futures were 0.10% and 0.33% lower, respectively.

The Dow closed 238.38 points higher on Monday as market participants backed stocks poised to benefit from an economic reopening.

SpreadEx's Connor Campbell said: "It's a big week for the US markets, but one that takes a while to get to the good stuff, with little of true value to tide investors over until Friday's potentially Fed-shifting nonfarm jobs report."

In the corporate space, Pfizer posted first-quarter revenues of $14.58bn, ahead of expectations of $13.51bn, and upped its full-year sales forecast from $15.0bn to $26.0bn. Elsewhere, news broke that the US looked set to approve the drugmaker's Covid-19 vaccine for 12-to-15-year-olds as early as next week.

CVS Health shares were also trading higher in pre-market after the pharmacy chain raised its full-year guidance.

On the macro front, trade balance numbers for March will be published at 1330 BST, while April's ISM New York Index and March factory orders figures will follow at 1445 BST and 1500 BST, respectively.